Celyad
ProfileJobs

Celyad

Suggest Edit
    • Healthbiotechhealthtechpharma

    Celyad is a biopharmaceutical company, specialized in cell therapy and developing of technologies to treat severe diseases with poor prognosis. The Company focuses on immuno oncology, cardiology, and medical devices.

    Market capitalization(2017-03-22)
    €190.4 B
    Type
    Public
    HQ
    Mont-Saint-Guibert, BE
    Founded
    2007
    Size (employees)
    79 (est)-3%
    Website
    celyad.com
    Celyad was founded in 2007 and is headquartered in Mont-Saint-Guibert, BE
    Report incorrect company information

    Key People/Management at Celyad

    Christian Homsy

    Christian Homsy

    Executive Director, CEO
    Patrick Jeanmart

    Patrick Jeanmart

    CFO, Investor Relations
    Jean-Pierre Latere

    Jean-Pierre Latere

    Chief Operating Officer (COO)
    Frederic Lehmann

    Frederic Lehmann

    VP Clinical Development and Medical Affairs
    David Gilham

    David Gilham

    VP Research & Development
    Philippe Dechamps

    Philippe Dechamps

    Chief Legal Officer
    Show more

    Celyad Office Locations

    Celyad has offices in Mont-Saint-Guibert and Boston
    Mont-Saint-Guibert, BE (HQ)
    2 Rue Edouard Belin
    Boston, US
    2 Seaport Ln
    Show all (2)
    Report incorrect company information

    Celyad Financials and Metrics

    Celyad Financials

    Market capitalization (22-Mar-2017)

    		190.4 b

    Closing share price (22-Mar-2017)

    		20.2
    Celyad's current market capitalization is €190.4 b.
    Show all financial metrics
    Report incorrect company information

    Competitors

    Catalyst Pharmaceuticals
    Health - Public
    Sorrento Therapeutics
    Health - Public
    Pernix Therapeutics
    Health - Public
    aTyr Pharma
    Health - Public
    Compare competitors
    Download PDF